RxDoctor Payments Data

Andrew Bloomfield, MD

Pain Medicine · Sun City Center, FLNPI 1699138875

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Saluda Medical Americas, Inc. accounts for 64.8% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $7,864, more than ten times the $316 reported in 2022.

$14,318in general payments, 2019–2025

Across 172 payments — averaging $83.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$9K
  • Foundation Fusion Solutions, LLC$2K
  • Boston Scientific$1K
  • Medtronic$456
  • Nevro Corp.$256
  • Abbott$217
  • plus $827 from 14 others
$1,600in research payments, 2019–2025

Across 1 payment — averaging $1600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Foundation Fusion Solutions, LLC$2K

What the payments were for

  • Consulting fees$5,25037%
  • Travel & lodging$1,66012%
  • Food & beverage$7,18150%
  • Entertainment$2262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,318 in reported general payments places this provider in the 85th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$275,202
Medicare patients
154
Services billed
11,714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen513$19,928
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen475$16,272
OxycontinOxycodone Hcl27$14,522
Oxycodone Hcl422$12,331
Xtampza ErOxycodone Myristate30$9,166
Tramadol Hcl ErTramadol Hcl65$8,608
Morphine Sulfate ErMorphine Sulfate350$8,566
Lidocaine40$7,402
Fentanyl58$6,389
Pregabalin96$3,553
Gabapentin209$3,152
Methocarbamol73$3,128
Morphine Sulfate59$2,147
Tizanidine Hcl242$2,138
Hydromorphone Hcl85$1,962

Paid to pharmacies, not to this prescriber.

Other pain medicine in Sun City Center

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →